Miscellaneous Notices




NEW ZEALAND GAZETTE, No. 29 — 7 APRIL 2016

Pursuant to section 164 of the Animal Products Act 1999, notice is given of the issue on 5 April 2016 of the Animal Products Notice: Official Assurances Specifications for Dairy Material and Dairy Products.

A copy of this notice may be inspected free of charge or purchased at a reasonable cost at the office of the Ministry for Primary Industries, 25 The Terrace, PO Box 2526, Wellington.

The notice can also be viewed on the MPI food safety website

www.foodsafety.govt.nz

Dated this 5th day of April 2016.

PAUL DANSTED, Manager Food Assurance, Ministry for Primary Industries (acting under delegated authority).

2016-go1925


Corrigendum—Classification of Medicines

In the notice published in the New Zealand Gazette, 25 February 2016, Issue No. 16, Notice No. 2016-go1070, in Schedule 1, Prescription Medicines, replace

"Steptozocin"

with

"Streptozocin".

Dated this 5th day of April 2016.

PHIL KNIPE, Acting Director, Protection Regulation and Assurance, Ministry of Health.

2016-go1926


Notice of Application to Register a Trade Name Product (Notice No. MPI 613)

Maree Zinzley, Manager Approvals Operations of the Ministry for Primary Industries (MPI), acting under delegated authority from the Director-General of MPI gives notice, under section 14(1) of the Agricultural Compounds and Veterinary Medicines Act 1997 ("Act"), that the following application has been made to register a trade name product under section 9(1) of the Act:

Trade Name: Marbocyl P

Reference: A011316

Active Ingredient and Concentrations:

Tablets contain 5mg, 20mg and 80mg marbofloxacin

Formulation Type: Oral tablet

General Use Claim:

For oral administration.

The recommended dose rate is 2mg/kg/d (1 tablet for 10kg per day) in single daily administration. To ensure a correct dosage, body weight should be determined as accurately as possible to avoid underdosing.

Dogs

In skin and soft tissue infections, treatment duration is at least five days. Depending on the course of the disease, it may be extended up to 40 days.

In urinary tract infections, treatment duration is at least ten days. Depending on the course of the disease, it may be extended up to 28 days.

In respiratory infections, treatment duration is at least seven days, and depending on the course of the disease it may be extended up to 21 days.

Cats (5mg tablet)

For skin and soft tissue infections (wounds, abscesses, phlegmons) treatment duration is three to five days.

For upper respiratory infections treatment duration is five days.

Any person may make a written submission to the director-general concerning this application.

Under sections 16 and 17 of the Act, a written submission:



Next Page →



Online Sources for this page:

Gazette.govt.nz PDF NZ Gazette 2016, No 29





✨ LLM interpretation of page content

🌾 Notice Under the Animal Products Act 1999 (continued from previous page)

🌾 Primary Industries & Resources
5 April 2016
Animal Products Act, Notice, Official Assurances Specifications, Dairy Material, Dairy Products
  • Paul Dansted, Manager Food Assurance, Ministry for Primary Industries

🏥 Corrigendum—Classification of Medicines

🏥 Health & Social Welfare
5 April 2016
Corrigendum, Medicines, Prescription Medicines, Streptozocin
  • Phil Knipe, Acting Director, Protection Regulation and Assurance, Ministry of Health

🌾 Notice of Application to Register a Trade Name Product

🌾 Primary Industries & Resources
Trade Name Product, Marbocyl P, Agricultural Compounds and Veterinary Medicines Act 1997, Application to Register
  • Maree Zinzley, Manager Approvals Operations, Ministry for Primary Industries